<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">850534</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.850534</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Biomimetic ZIF8 Nanosystem With Tumor Hypoxia Relief Ability to Enhance Chemo-Photothermal Synergistic Therapy</article-title>
<alt-title alt-title-type="left-running-head">Zhao et al.</alt-title>
<alt-title alt-title-type="right-running-head">Biomimetic Nanosystem for Tumor Therapy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Ziming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1635788/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhaorong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hua</surname>
<given-names>Yabing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Yuanjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Ge</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Shengyue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1650571/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Cong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yanzhuo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Yihua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1621768/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy</institution>, <institution>Xuzhou Medical University</institution>, <addr-line>Xuzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmaceutics</institution>, <institution>School of Pharmacy</institution>, <institution>Xuzhou Medical University</institution>, <addr-line>Xuzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/825619/overview">Zeming Liu</ext-link>, Huazhong University of Science and Technology, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1628330/overview">Xiongwei Deng</ext-link>, National Center for Nanoscience and Technology (CAS), China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/826509/overview">Haibo Zhou</ext-link>, Jinan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1200275/overview">Yelin Wu</ext-link>, Tongji University School of Medicine, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yanzhuo Zhang, <email>yanzhuozhang@126.com</email>; Yihua Yang, <email>nancyyyh@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>850534</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhao, Liu, Hua, Pan, Yi, Wu, He, Zhang and Yang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhao, Liu, Hua, Pan, Yi, Wu, He, Zhang and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Tumor hypoxic microenvironment can reduce the therapeutic effects of chemotherapy, radiotherapy, photodynamic therapy, immunotherapy, etc. It is also a potential source of tumor recurrence and metastasis. A biomimetic nanosystem based on zeolitic imidazolate framework 8 (ZIF8), which had multifunctions of hypoxia relief, chemotherapy, and photothermal therapy, was established to improve tumor hypoxic microenvironment and overcome the corresponding therapeutic resistance. ZIF8 enveloped with DOX and CuS nanoparticles (DC&#x0040;ZIF8) was synthesized by a sedimentation method. Red blood cell membrane and catalase (CAT) were coated onto DC&#x0040;ZIF8 and biomimetic nanosystem (DC&#x0040;ZIF8-MEM<sub>C</sub>) was formed. The designed DC&#x0040;ZIF8-MEM<sub>C</sub> had a shape of polyhedron with an average particle size around 254&#xa0;nm. The loading content of DOX, CAT, and CuS was 4.9%, 6.2%, and 2.5%, separately. The release of DOX from DC&#x0040;ZIF8-MEM<sub>C</sub> was pH dependent and significantly faster at pH 5 due to the degradation of ZIF8. DC&#x0040;ZIF8-MEM<sub>C</sub> exhibited outstanding photothermal conversion properties and excellent antitumor effect <italic>in vitro</italic> and <italic>in vivo.</italic> Moreover, the hypoxia relief by CAT was proved to have good sensitization effect on chemo-photothermal combined therapy. DC&#x0040;ZIF8-MEM<sub>C</sub> is a prospective nanosystem, which can realize great chemo-photothermal synergistic antitumor effect under the sensitization of CAT. The biomimetic multifunctional nanoplatform provides a potential strategy of chemo-photothermal synergistic antitumor effect under the sensitization of CAT.</p>
</abstract>
<kwd-group>
<kwd>biomimetic</kwd>
<kwd>ZIF8</kwd>
<kwd>photothermal therapy</kwd>
<kwd>chemotherapy</kwd>
<kwd>hypoxia relief</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Cancer has become one of the major diseases threatening human health and life (<xref ref-type="bibr" rid="B12">Li D. et al., 2021</xref>). The conventional clinical methods, such as chemotherapy (CT), surgery, radiation therapy, have made remarkable achievement in the treatment of cancer. However, therapeutic outcomes are unsatisfactory, and patient compliance is poor, resulting from far-reaching side effects (<xref ref-type="bibr" rid="B15">Li et al., 2019</xref>). Researchers have devoted to develop new approaches, such as photothermal therapy (PTT), photodynamic therapy (PDT), chemodynamic therapy (CDT), immunotherapy, gene therapy, and molecular targeted therapy.</p>
<p>As one of the rising &#x201c;green&#x201d; cancer treatment methods, PTT based on photothermal agents converts energy from near infrared (NIR) light into heat, leading to overheating of the surrounding environment and inducing cancer cell death (<xref ref-type="bibr" rid="B2">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="B10">Jiang et al., 2019</xref>). Photothermal agents, such as gold nanorods (<xref ref-type="bibr" rid="B7">He et al., 2021</xref>), carbon nanorods (<xref ref-type="bibr" rid="B42">Zhao et al., 2021</xref>), palladium nanorods (<xref ref-type="bibr" rid="B29">Tang et al., 2014</xref>), semiconducting polymer nanoparticles (<xref ref-type="bibr" rid="B43">Zhen et al., 2018</xref>), NIR dyes (<xref ref-type="bibr" rid="B37">Yue et al., 2013</xref>; <xref ref-type="bibr" rid="B41">Zhao et al., 2014</xref>), polydopamine (PDA) (<xref ref-type="bibr" rid="B3">Ding et al., 2016</xref>), and copper sulfide (CuS) (<xref ref-type="bibr" rid="B8">Jang et al., 2018</xref>; <xref ref-type="bibr" rid="B25">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="B13">Li J. et al., 2021</xref>) have been reported as having good photothermal effect. However, PTT may lead to uneven heat distribution and subsequent sublethal thermal dose in the treatment area (<xref ref-type="bibr" rid="B10">Jiang et al., 2019</xref>; <xref ref-type="bibr" rid="B38">Zhang L. et al., 2019</xref>). Moreover, utilizing PTT alone to treat tumor is suboptimal and unreliable. Generally, co-delivery of chemotherapeutic drug and photothermal agent simultaneously exerts two benefits to improve antitumor efficacy. As is well known, a combination therapy of CT and PTT based on nanomaterials exhibits significant advantages over monotherapy for anticancer treatment and usually generates synergistic therapeutic efficacies with minimal side effects (<xref ref-type="bibr" rid="B17">Liu et al., 2011</xref>; <xref ref-type="bibr" rid="B14">Li et al., 2018</xref>; <xref ref-type="bibr" rid="B15">Li et al., 2019</xref>).</p>
<p>CT based on nanocarrier to deliver a chemical drug is effective. As a new kind of porous material, ZIF8 is built from zinc ions and 2-methylimidazolate, which are components of physiological systems (<xref ref-type="bibr" rid="B46">Zhuang et al., 2014</xref>). It possesses unique merits including significantly high microporosity, excellent structural regularity, adjustable surface functionality, and intrinsic pH-induced biodegradability (<xref ref-type="bibr" rid="B27">Sun et al., 2012</xref>; <xref ref-type="bibr" rid="B18">Liu H et al., 2021</xref>). In addition, it is prone to decompose under acidic conditions (pH 5.0&#x2013;6.0), which is helpful to the pH-controlled delivery and release of the loaded payloads (<xref ref-type="bibr" rid="B21">Park et al., 2006</xref>; <xref ref-type="bibr" rid="B16">Lian et al., 2017</xref>; <xref ref-type="bibr" rid="B4">Gao et al., 2019</xref>). A theranostic nanoplatform based on ZIF8 encapsulated Pd nanosheets and DOX (DOX/Pd@ZIF8@PDA) showed photoacoustic (PA) imaging-guided synergetic photo-chemo cancer therapy (<xref ref-type="bibr" rid="B44">Zhu et al., 2019</xref>). A drug delivery nanoplatform based on ZIFs (PDA-PCM&#x0040;ZIF8/DOX) exhibited drug release as high as 78% under the dual stimulus of NIR and acid environment (<xref ref-type="bibr" rid="B33">Wu et al., 2018</xref>).</p>
<p>Moreover, hypoxia is a unique feature of tumor microenvironment due to rapid cell proliferation and abnormal vascular structure (<xref ref-type="bibr" rid="B31">Vaupel and Mayer, 2016</xref>; <xref ref-type="bibr" rid="B6">Graham and Unger, 2018</xref>). Numerous studies have demonstrated that tumoral hypoxia can activate the overexpression of P-glycoproteins (P-gp), which markedly reduced the effect of CT (<xref ref-type="bibr" rid="B24">Samanta et al., 2014</xref>.). Hypoxia also induces tumor gene mutations and subsequent proteomic changes, ultimately impeding the clinical therapeutic effect of cancer therapy (<xref ref-type="bibr" rid="B11">Jing et al., 2019</xref>). Additionally, cancerous cells produced excessive amounts of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in tumor regions, resulting in oxide stress (<xref ref-type="bibr" rid="B28">Szatrowski and Nathan, 1991</xref>; <xref ref-type="bibr" rid="B26">Song et al., 2016</xref>). Using H<sub>2</sub>O<sub>2</sub>-responsive enzyme is an intriguing strategy to overcome tumor hypoxia (<xref ref-type="bibr" rid="B28">Szatrowski and Nathan, 1991</xref>; <xref ref-type="bibr" rid="B1">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B39">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B47">Zou et al., 2018</xref>; <xref ref-type="bibr" rid="B36">Yin et al., 2020</xref>). CAT, an enzyme, is capable of catalyzing H<sub>2</sub>O<sub>2</sub> to oxygen (O<sub>2</sub>) efficiently, leading to tumor hypoxia relief (<xref ref-type="bibr" rid="B19">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="B36">Yin et al., 2020</xref>).</p>
<p>Herein, we developed ZIF8 NPs to load CuS NPs and DOX&#x00B7;HCl, then camouflaged with bionic surface material, red cell membrane (MEM) combined with CAT, to construct a biomimetic nanosystem with multifunctions of chemotherapy, hyperthermia treatment, and hypoxia relief (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic illustration for the formation of DC&#x0040;ZIF8-MEM<sub>C</sub> nanoplatform.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials" id="s2">
<title>Materials</title>
<sec id="s2-1">
<title>Reagents</title>
<p>Copper (II) chloride dihydrate (CuCl<sub>2</sub>&#x00B7;2H<sub>2</sub>O, analytical grade), sodium citrate dihydrate (Na<sub>3</sub>C<sub>6</sub>H<sub>5</sub>O<sub>7</sub>&#x00B7;2H<sub>2</sub>O, analytical grade), sodium sulfide nonahydrate (Na<sub>2</sub>S&#xb7;9H<sub>2</sub>O, analytical grade), and polyvinylpyrrolidone K30 (PVP K30, analytical grade) were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). <ext-link ext-link-type="uri" xlink:href="https://www.so.com/link?m=b13KKzQDrV76v5yZZOUOymeXuvLYtFCcc5PdkLPMtr%2BHADLJxZEwBSX%2BzjiNGFHU9W3KOOqT3pyNphTTeHpWsLxT7Ic3wL9z4NeMPZ5wD1N3rWztGQhcvKgvazzD4G2vq6o%2FJqVi265F7Ayo2Hgzy1fioiGmuaYxOK7t4guR2C54%3D">Zinc acetate dihydrate</ext-link> [Zn (CH<sub>3</sub>CO<sub>2</sub>) &#xb7; 2H<sub>2</sub>O, 98%], 2-methylimidazole (98%), catalase (CAT) were purchased from Aladdin Chemistry Co., Ltd. (Shanghai, China). Tris (4,7-diphenyl-1,10-phenanthroline)-ruthenium (II) dichloride [Ru (dpp)<sub>3</sub>Cl<sub>2</sub>, 98%] was obtained from Rhawn Reagent Co., Ltd. (Shanghai, China). Doxorubicin hydrochloride (DOX&#x00B7;HCl, 98%) was supplied from Aladdin Chemistry Co., Ltd. (Shanghai, China). BCA Protein Assay Kit, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT, 98%) and hoechst 33258 were obtained from Beyotime Biotechnology Co., Ltd. (Shanghai, China). Cell Viability/Cytotoxicity Detec (Calcein AM/PI) was obtained from Yuanye Bio-Technology Co., Ltd (Shanghai, China).</p>
</sec>
<sec id="s2-2">
<title>Cells</title>
<p>Mouse breast cancer cells (4T1) and leukemia cells in mouse macrophage (RAW264.7) were obtained from the Chinese Academy of Sciences (Shanghai, China). The 4T1 cells were incubated with DMEM/f12 medium containing 10% FBS, 1% streptomycin (50&#xa0;U&#x00B7;mL<sup>&#x2212;1</sup>), and penicillin (50&#xa0;U&#x00B7;mL<sup>&#x2212;1</sup>) in a 5% CO<sub>2</sub> atmosphere at 37&#xb0;C. The RAW264.7 cells were cultured in DMEM medium supplemented with 10% FBS, 1% streptomycin (50&#xa0;U&#x00B7;mL<sup>&#x2212;1</sup>), and penicillin (50&#xa0;U&#x00B7;mL<sup>&#x2212;1</sup>) in a 5% CO<sub>2</sub> atmosphere at 37&#xb0;C.</p>
</sec>
<sec id="s2-3">
<title>Animals</title>
<p>BALB/c female mice (20&#xa0;&#xb1;&#xa0;2&#xa0;g) were purchased from the Laboratory Animal Center of Xuzhou Medical University (Xuzhou, China), and maintained in a sterile environment, and allowed free access to food and water, and all experiment procedures were approved by the Experimental Animal Ethics Committee of Xuzhou Medical University and carried out by the guidelines of the National Act on the Use of Experimental Animals (People&#x2019;s Republic of China).</p>
</sec>
</sec>
<sec sec-type="methods" id="s3">
<title>Methods</title>
<sec id="s3-1">
<title>Preparation of DC&#x0040;ZIF8-MEM<sub>C</sub>
</title>
<sec id="s3-1-1">
<title>Preparation of CuS NPs</title>
<p>CuCl<sub>2</sub>&#x00B7;2H<sub>2</sub>O (0.4&#xa0;mM) and Na<sub>3</sub>C<sub>6</sub>H<sub>5</sub>O<sub>7</sub>&#x00B7;2H<sub>2</sub>O (0.27&#xa0;mM) were dissolved in 180&#xa0;ml of deionized water, and then 20&#xa0;ml of Na<sub>2</sub>S&#xb7;9H<sub>2</sub>O (0.4&#xa0;mM) aqueous solution was added to the mixed solution. After stirring for 5&#xa0;min at room temperature, the mixed solution was stirred for 15&#xa0;min at 90&#xb0;C, until dark green was obtained. The synthesized product was centrifuged and then washed with deionized water three times yielding CuS NPs.</p>
</sec>
<sec id="s3-1-2">
<title>Preparation of DC&#x0040;ZIF8</title>
<p>2-Methylimidazole (460&#xa0;mg) and PVP K30 (25&#xa0;mg) were dissolved in 10&#xa0;ml of CuS aqueous solution (2&#xa0;mM), 1&#xa0;ml of zinc acetate methanol solution (0.56&#xa0;mM) was added and stirred for 10&#xa0;min, centrifuged, dried under vacuum to obtain CuS NPs-loaded ZIF8 NPs (C&#x0040;ZIF8). DOX&#x00B7;HCl (1&#xa0;mg) was mixed with 12&#xa0;mg&#xa0;C&#x0040;ZIF8, dissolved in distilled water, and stirred for 10&#xa0;min, centrifuged, and washed to collect DC&#x0040;ZIF8.</p>
</sec>
<sec id="s3-1-3">
<title>Extraction of Red Blood Cell Membrane</title>
<p>Red blood cell (RBC) membranes were obtained according to a reported method with modification (<xref ref-type="bibr" rid="B23">Piao et al., 2014</xref>). Fresh whole blood from male ICR mice (20&#x2013;22&#xa0;g) was collected with heparinized tubes, followed by centrifugation for 10&#xa0;min with 4,000&#xa0;rpm at 4&#xb0;C to remove the plasma and the leukocytes. The collected red blood cells (RBCs) were washed with 1&#xd7; PBS, suspended with 0.25&#xd7; PBS for 30&#xa0;min at 4&#xb0;C, and then centrifuged at 10,000&#xa0;rpm for 10&#xa0;min. The resulting light-pink pellet was purified with 1&#xd7; PBS, which yielded RBC membrane (<xref ref-type="bibr" rid="B23">Piao et al., 2014</xref>).</p>
</sec>
</sec>
<sec id="s3-2">
<title>Preparation of DC&#x0040;ZIF8-MEM<sub>C</sub>
</title>
<p>The above prepared DC&#x0040;ZIF8 and CAT were dispersed in 10&#xa0;ml of RBC membrane solution and then ultrasonicated with ice bath for 6&#xa0;min. The precipitation of DC&#x0040;ZIF8-MEM<sub>C</sub> was collected by washing and centrifugation, and placed at 4&#xb0;C for later use. DC&#x0040;ZIF8-MEM was prepared by the same method above except for the absence of CAT.</p>
</sec>
<sec id="s3-3">
<title>Characterization</title>
<sec id="s3-3-1">
<title>Morphology, Size, and Zeta Potential</title>
<p>The particle size and zeta potential were determined by dynamic light scattering (DLS) method using a NicompTM 380 ZLS zeta potential/size analyzer (Particle Sizing Systems, Santa Banta, CA, USA) at 25&#xb0;C. The morphologies of the NPs were observed using transmission electron microscopy (TEM) (FEI Tecnai G2 Spirit Twin, Holland).</p>
</sec>
</sec>
<sec id="s3-4">
<title>Load Efficiency</title>
<p>The loading content (LC) was calculated using the following formula: LC&#xa0;&#x3d;&#xa0;weight of loaded drug/weight of NPs&#x2a;100%. DOX&#x00B7;HCl was quantitatively analyzed using fluorescence spectrum (excitation wavelength&#xa0;&#x3d;&#xa0;488&#xa0;nm, emission wavelength&#xa0;&#x3d;&#xa0;560&#xa0;nm). The quantification of CAT was determined by ultraviolet spectrophotometer based on ammonium molybdate colorimetric method. The NPs were digested by nitric acid, and Cu<sup>2&#x2b;</sup> content was detected by an inductively coupled plasma spectrometer (PQ9000, German), and then the LC of CuS was analyzed.</p>
</sec>
<sec id="s3-5">
<title>Spectra Analysis</title>
<p>Infrared spectra and ultraviolet (UV)-visible (UV-vis) spectra were obtained by using a Fourier transform infrared spectrometer (FTIR, BRUKER) and an Evolution 220 UV-Visible Spectrophotometer (Mapada Instruments, Shanghai), respectively.</p>
<sec id="s3-5-1">
<title>Drug release <italic>in vitro</italic>
</title>
<p>The release study was assessed by the dialysis method. The release media was PBS solutions with different pH values (5.0, 6.5, and 7.4). Briefly, 5&#xa0;ml of DOX&#x00B7;HCl-loaded NPs was placed in a dialysis bag (MWCO 8,000&#x2013;14,000) and dialyzed against 45&#xa0;ml of buffer medium under mechanical shaking (100&#xa0;rpm) at 37&#xb0;C. At predesigned time, 5&#xa0;ml of release medium was withdrawn and replenished with an equal volume of fresh medium. The released DOX&#x00B7;HCl was detected by Fluorescence spectrum.</p>
</sec>
</sec>
<sec id="s3-6">
<title>pH Sensitivity</title>
<p>DC&#x0040;ZIF8-MEM<sub>C</sub> was incubated with 10&#xa0;mM PBS (pH 7.4 or pH 5.0) at 37&#xb0;C for 8&#xa0;h, and the morphology or size was detected.</p>
</sec>
<sec id="s3-7">
<title>Stability</title>
<p>DC&#x0040;ZIF8-MEM<sub>C</sub> was suspended in PBS (pH 7.4, 10&#xa0;mM) or 10% fetal bovine serum (FBS), and measurements were performed in triplicate at different intervals.</p>
<sec id="s3-7-1">
<title>Photothermal Activity <italic>in vitro</italic>
</title>
<p>The photothermal conversion capability of DC&#x0040;ZIF8-MEM<sub>C</sub> was investigated. Various concentrations of DC&#x0040;ZIF8-MEM<sub>C</sub> (0, 60, 125, 250&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>) were dispersed in 1&#xa0;ml of deionized water and irradiated by 808&#xa0;nm NIR laser at 2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup> for 5&#xa0;min. The temperature of each sample was monitored by a FLIR imaging instrument.</p>
<p>DC&#x0040;ZIF8-MEM<sub>C</sub> (250&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1)</sup> was dispersed in 1&#xa0;ml of deionized water and irradiated by 808&#xa0;nm NIR laser at different power densities (0.5, 1.0, 1.5, 2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) for 5&#xa0;min. The temperature of each sample was monitored by a FLIR imaging instrument.</p>
<p>To evaluate the photothermal stability of NPs, 1&#xa0;ml of DC&#x0040;ZIF8-MEM<sub>C</sub> was irradiated by 808&#xa0;nm laser (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) for four laser ON/OFF cycles. The photothermal conversion efficiency (&#x3b7;) of DC&#x0040;ZIF8-MEM<sub>C</sub> was calculated as follows according to a previously reported method (<xref ref-type="bibr" rid="B40">Zhang X. et al., 2019</xref>):<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext>&#x3b7;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mi>S</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mrow>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>x</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mrow>
<mml:mi>s</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>Q</mml:mi>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mtext>I</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mn>10</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>A</mml:mtext>
<mml:mn>808</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>where h represents heat-transfer coefficient, S represents the irradiated area, T<sub>max</sub> represents the equilibrium temperature, T<sub>surr</sub> is ambient temperature of the surrounding, Q<sub>dis</sub> is the heat associated with the light absorbance of the solvent, I is the power density of the laser (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>), and A<sub>808</sub> is the absorption value of the material at 808&#xa0;nm (<xref ref-type="bibr" rid="B40">Zhang X. et al., 2019</xref>). Photothermal conversion of DC@ZIF8 was performed the same above.</p>
</sec>
</sec>
<sec id="s3-8">
<title>O<sub>2</sub> Generation <italic>in vitro</italic>
</title>
<p>The fluorescence of O<sub>2</sub>-sensitive fluorescent probe Tris (4,7-diphenyl-1,10-phenanthroline) ruthenium (II) dichloride [Ru (DPP)<sub>3</sub>Cl<sub>2</sub>] will be quenched to a certain extent when O<sub>2</sub> concentration is sufficient. H<sub>2</sub>O<sub>2</sub> solution (10&#xa0;mM), Ru (DPP)<sub>3</sub>Cl<sub>2</sub> solution (1&#xa0;mM), and DC&#x0040;ZIF8-MEM<sub>C</sub> (125&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>) were mixed and sealed. The emission spectra were scanned at a predetermined time (0, 10, 20, 30, 45, 60&#xa0;min).</p>
<p>Additionally, the portable dissolved oxygen meter was used to measure the <italic>in situ</italic> O<sub>2</sub> generation. Free CAT, DC&#x0040;ZIF8-MEM<sub>C</sub>, DC&#x0040;ZIF8-MEM, and PBS were mixed with H<sub>2</sub>O<sub>2</sub> solution (10&#xa0;mM), and the O<sub>2</sub> production was dynamically detected by the portable dissolved oxygen meter (JPBJ-609L, INESA Scientific Instrument Co., Ltd., China) every 30&#xa0;s for 600&#xa0;s.</p>
</sec>
<sec id="s3-9">
<title>Catalase activity</title>
<p>Catalase activity was evaluated by the Goth method (<xref ref-type="bibr" rid="B5">Goth, 1991</xref>). Free CAT, DC&#x0040;ZIF8-MEM<sub>C</sub> [(CAT)&#xa0;&#x3d;&#xa0;2.5&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>] and DC&#x0040;ZIF8-MEM were incubated with H<sub>2</sub>O<sub>2</sub> solution (50&#xa0;mM) at 37&#xb0;C, then ammonium molybdate was added to terminate the reaction, and the absorbance was determined at 400&#xa0;nm according to a standard curve of H<sub>2</sub>O<sub>2.</sub> CAT was reliable to degrade by the protease K under complicated physiological conditions (<xref ref-type="bibr" rid="B22">Phua et al., 2019</xref>). Free CAT and DC&#x0040;ZIF8-MEM<sub>C</sub> was incubated with protease K (100&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>) at 37&#xb0;C, and then the absorbance was determined according to the method above.</p>
</sec>
<sec id="s3-10">
<title>Cell Experiments</title>
<sec id="s3-10-1">
<title>Cellular Uptake</title>
<p>4T1 cells were seeded at a density of 2&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well in 48-well plates and treated with samples (DOX&#x00B7;HCl, DC&#x0040;ZIF8, DC&#x0040;ZIF8-MEM<sub>C</sub>) at an equivalent DOX&#x00B7;HCl concentration of 1&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>, respectively. After incubation for 4&#xa0;h, the cells were washed by PBS, and then the cell nuclei were stained with Hoechst 33258 for 10&#xa0;min. Afterward, the cells were observed under an inverted fluorescence microscopy.</p>
<p>The cellular uptake was quantified using a microplate reader following the procedure (<xref ref-type="bibr" rid="B32">Win and Feng, 2005</xref>). 4T1 cells were seeded in 96-well plates at a density of 1&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well. After cell attachment, fresh media containing different formulations [(DOX&#x00B7;HCl)&#xa0;&#x3d;&#xa0;1&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>] were added and incubated for 4&#xa0;h. After washing with PBS, the cells were treated with 0.5% of TritonX-100 solution for 30&#xa0;min. Fluorescence intensity of cell lysates (E<sub>x</sub>&#xa0;&#x3d;&#xa0;480&#xa0;nm, E<sub>m</sub>&#xa0;&#x3d;&#xa0;595&#xa0;nm) was determined by a fluorescence microplate. Uptake efficiency (%)&#xa0;&#x3d;&#xa0;W<sub>sample</sub>/W<sub>total</sub> &#x2a;100%</p>
</sec>
<sec id="s3-10-2">
<title>Cytotoxicity <italic>in vitro</italic>
</title>
<p>The <italic>in vitro</italic> cytotoxicity was evaluated by using MTT assay. 4T1 cells pre-seeded at a density of 1&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well in 96-well plates were incubated with different samples at gradient concentrations for 24&#xa0;h. For NIR irradiation treatment, cells were irradiated by 808&#xa0;nm for 3&#xa0;min (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) after 6&#xa0;h of incubation and then incubated for further 18&#xa0;h. Then 20&#xa0;&#x3bc;l of MTT was added and incubated for another 4&#xa0;h. Subsequently, all of the solutions were replaced with 150&#xa0;&#xb5;l dimethyl sulfoxide (DMSO). The absorbance was determined by using a microplate reader at 490&#xa0;nm. The untreated cells in medium were regarded as control. The cell viabilities (%) were calculated according to the reported literature (<xref ref-type="bibr" rid="B47">Zou et al., 2018</xref>).</p>
<p>4T1 cells seeded at a density of 1&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well in 96-well plates and incubated at different samples with hypoxic incubator (1% O<sub>2</sub>) for 24&#xa0;h. Then 10&#xa0;&#xb5;M H<sub>2</sub>O<sub>2</sub> was added, and the cell viabilities were calculated the same as above.</p>
<p>Calcein AM/PI double staining kit was performed to evaluate live/dead cells (<xref ref-type="bibr" rid="B19">Liu et al., 2019</xref>). The 4T1 cells were seeded at a density of 1&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well in 96-well plates and cultured overnight. The media were replaced with DOX&#x00B7;HCl, DC&#x0040;ZIF8-MEM<sub>C</sub> [(DOX&#x00B7;HCl)]&#xa0;&#x3d;&#xa0;3.5&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>], and incubated for 24&#xa0;h. For the laser group, the cells were irradiated by 808 nm NIR (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) for 3&#xa0;min after 8&#xa0;h of incubation, and then continued for 16&#xa0;h of incubation. Calcein-AM (2&#xa0;&#x3bc;M) and PI (4.5&#xa0;&#x3bc;M) were added and incubated for 30&#xa0;min. The cells were washed with PBS and observed under an inverted fluorescence microscope.</p>
</sec>
</sec>
<sec id="s3-11">
<title>Intracellular Location</title>
<p>4T1 cells were inoculated and incubated overnight at a density of 1&#xa0;&#xd7;&#xa0;10<sup>5</sup> cells/dish in laser confocal Petri dishes. Fresh medium containing DC&#x0040;ZIF8-MEM<sub>C</sub> [(DOX&#x00B7;HCl)&#xa0;&#x3d;&#xa0;1&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>] was added and incubated for 0.5, 2, 6&#xa0;h, respectively. The samples were washed with PBS and then stained with Lysotracker for 20&#xa0;min and Heochst-33258 for 10&#xa0;min. Intracellular location was observed by confocal laser microscopy (CLMS) and analyzed by ImageJ software (<xref ref-type="bibr" rid="B45">Zhu et al., 2018</xref>).</p>
</sec>
<sec id="s3-12">
<title>Immune Evasion</title>
<p>RAW 264.7 cells were selected as a macrophage model to demonstrate that the composite vector coated by blood cells can reduce the probability of being phagocytosed by macrophages. RAW 264.7 cells were seeded at density of 1&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well in 96-well plates and incubated overnight. Different samples (DOX&#x00B7;HCl, DC&#x0040;ZIF8, and DC&#x0040;ZIF8-MEM<sub>C</sub>, with DOX&#x00B7;HCl concentration 1&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>) were added, and incubated for 4&#xa0;h. The medium was discarded, and Heochst-33258 was used as a stain for 10&#xa0;min. Cell uptake was observed by inverted fluorescence microscopy. The quantitative uptake was investigated similarly as described above.</p>
</sec>
<sec id="s3-13">
<title>Intracellular Oxygen Determination</title>
<p>4T1 cells were seeded at a density of 4&#xa0;&#xd7;&#xa0;10<sup>4</sup> cells/well into 24-well plates, and 10&#xa0;&#xb5;M H<sub>2</sub>O<sub>2</sub> was added for 2&#xa0;h with a hypoxic incubator. Different samples were added and incubated for 4&#xa0;h. Ru (DPP)<sub>3</sub>Cl<sub>2</sub> (0.5&#xa0;&#xb5;M) was added for 1&#xa0;h and observed by an inverted fluorescence microscopy.</p>
</sec>
<sec id="s3-14">
<title>Tumor Inhibition Effect <italic>in vivo</italic>
</title>
<p>The animal model was built by subcutaneous injection with 100&#xa0;&#xb5;l of 4T1 cells (1&#xa0;&#xd7;&#xa0;10<sup>6</sup> cells) in the right hind limb of female BALB/c mice. The tumor-bearing mice were randomly divided into seven groups (each group had five mice with similar tumor volume about 200&#xa0;&#xb1;&#xa0;20&#xa0;mm<sup>3</sup>): 1) PBS group, 2) DOX&#x00B7;HCl group, 3) C&#x0040;ZIF8-MEM group; 4) D&#x0040;ZIF8-MEM group; 5) DC&#x0040;ZIF8-MEM&#xa0;&#x2b;&#xa0;NIR group; 6) DC&#x0040;ZIF8-MEM<sub>C</sub> group; 7) DC&#x0040;ZIF8-MEM<sub>C</sub>&#xa0;&#x2b;&#xa0;NIR group. The mice were treated with PBS (group 1), NPs (groups 2 to 7, with a dosage of DOX&#x00B7;HCl 5&#xa0;mg&#x00B7;kg<sup>&#x2212;1</sup>) <italic>via</italic> tail vein injection at day&#xa0;0, 3, 6, and 9 for an overall of four times. For the NIR groups, the mice were treated with NIR 808&#xa0;nm irradiation (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) at the tumor site for 5&#xa0;min after 8&#xa0;h post-injection. Tumor volume was calculated by the formula (a&#xa0;&#xd7;&#xa0;b<sup>2</sup>)/2, where a and b are the long and short diameters of the tumor, respectively, which were measured every other day by a vernier caliper (<xref ref-type="bibr" rid="B33">Wu et al., 2018</xref>).</p>
<p>On day&#xa0;14, the mice were sacrificed, and major organs, including the heart, liver, spleen, lungs, kidneys, and tumor were collected for pathological evaluation.</p>
</sec>
<sec id="s3-15">
<title>Photothermal Effect <italic>in vivo</italic>
</title>
<p>The tumor-bearing mice were tail vein injected with PBS, DC&#x0040;ZIF8, DC&#x0040;ZIF8-MEM, and DC&#x0040;ZIF8-MEM<sub>C</sub>. After an 8&#xa0;h-injection, the mice were anesthetized with 40&#xa0;&#x3bc;l of 10% chloral hydrate by intraperitoneal injection. The tumor site of the mice was irradiated by 808&#xa0;nm of NIR (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) for 5&#xa0;min. Simultaneously, the photothermal imaging of the tumor site was recorded by the near-infrared imager. The temperature change in the tumor site with time was observed, and the temperature curve was plotted.</p>
</sec>
<sec id="s3-16">
<title>Hemolysis Assay</title>
<p>The hemocompatibility was evaluated by hemolysis assay (<xref ref-type="bibr" rid="B34">Yang et al., 2019</xref>). First, fresh blood extracted from rabbit heart was centrifuged at 3,000&#xa0;rpm for 15&#xa0;min and purified with normal saline (NS) to obtain erythrocytes. DC&#x0040;ZIF8-MEM<sub>C</sub> with various concentrations were mixed with the 2% erythrocytes (v/v) and incubated for 3&#xa0;h. Afterward, the mixtures were centrifuged at 3,500&#xa0;rpm for 15&#xa0;min, and the absorbance (A) of the sample supernatant at 540&#xa0;nm was measured by UV-vis spectrophotometer. PBS (0.01&#xa0;M, pH 7.4) and deionized water were regarded as the negative and positive controls, respectively. The hemolysis ratio (HR) was calculated as follows: HR (%)&#xa0;&#x3d;&#xa0;(A<sub>sample</sub>&#xa0;&#x2212;&#xa0;A<sub>negative control</sub>)/(A<sub>positive control</sub>&#xa0;&#x2212;&#xa0;A<sub>negative control)</sub>&#xa0;&#x2a;&#xa0;100%.</p>
</sec>
<sec id="s3-17">
<title>Statistical Analysis</title>
<p>The data were expressed as the mean&#xa0;&#xb1;&#xa0;standard deviation (SD). Statistical analysis was performed using a two-tailed Student&#x2019;s t-test and analysis of variance (ANOVA) with the software SPSS 23.0. All analyses were shown compared with the control, and the significance of the difference was indicated as &#x2a;<italic>p&#xa0;</italic>&#x3c;&#xa0;0.05, &#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01, or &#x2a;&#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s4">
<title>Results and discussion</title>
<sec id="s4-1">
<title>Synthesis and Characterization</title>
<p>CuS NPs appeared dark green (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). Both DC&#x0040;ZIF8 and DC&#x0040;ZIF8-MEM<sub>C</sub> showed purplish red due to the loaded DOX&#x00B7;HCl (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). CuS NPs were spherical, while DC&#x0040;ZIF8 was polyhedral due to the frame of ZIF8 by TEM (<xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>). After coating with MEM-embedded CAT, DC&#x0040;ZIF8-MEM<sub>C</sub> maintained a polyhedral structure by TEM (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The size of CuS NPs was only 7&#xa0;nm, and C&#x0040;ZIF8 increased to 230&#xa0;nm due to the framework of ZIF8 (<xref ref-type="fig" rid="F2">Figure 2B</xref>). After drug loading, the size of DC&#x0040;ZIF8 was 232&#xa0;nm, and the size of DC&#x0040;ZIF8-MEM<sub>C</sub> increased to 254&#xa0;nm for the coating of cell membrane (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Both C&#x0040;ZIF8 and DC&#x0040;ZIF8 were positive zeta potential (<xref ref-type="fig" rid="F2">Figure 2C</xref>). However, the zeta potential of DC&#x0040;ZIF8-MEM<sub>C</sub> reversed to be negative (&#x2212;9.3&#xa0;mV), demonstrating a successful membrane coating (<xref ref-type="fig" rid="F2">Figure 2C</xref>). DOX&#x00B7;HCl was quantitatively analyzed by fluorescence spectrum (<xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>). The CAT was quantitatively analyzed by ultraviolet spectrophotometer (<xref ref-type="sec" rid="s12">Supplementary Figure S4</xref>). The LC of DOX, CAT, and CuS was 4.9%, 6.2%, and 2.5%, separately. Moreover, DC&#x0040;ZIF8-MEM<sub>C</sub> exhibit good colloidal stability in both PBS and 10% FBS, as indicated by the negligible increase in hydrodynamic diameter (<xref ref-type="sec" rid="s12">Supplementary Figure S5</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Representative transmission electron microscopy (TEM) image of DC&#x0040;ZIF8-MEM<sub>C</sub> (scale bar&#xa0;&#x3d;&#xa0;100&#xa0;nm) <bold>(A)</bold>. Size of preparations <bold>(B)</bold>. Zeta potential of preparations <bold>(C)</bold>. Ultraviolet (UV)-visible (UV-Vis) analysis <bold>(D)</bold>. Fourier transform infrared (FTIR) analysis <bold>(E)</bold>. DOX&#x00B7;HCl release profiles from DC&#x0040;ZIF8-MEM<sub>C</sub> under PBS at pH values of 5.0, 6.5, and 7.4 <bold>(F)</bold>. Size and TEM image (inserted) of DC&#x0040;ZIF8-MEM<sub>C</sub> with PBS (pH 5.0) for 8&#xa0;h; scale bar&#xa0;&#x3d;&#xa0;100&#xa0;nm <bold>(G)</bold>. Size and TEM image (inserted) of DC&#x0040;ZIF8-MEM<sub>C</sub> with PBS (pH 7.4) for 8&#xa0;h; scale bar&#xa0;&#x3d;&#xa0;100&#xa0;nm <bold>(H)</bold>.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g002.tif"/>
</fig>
<p>UV-Vis analysis showed that DC&#x0040;ZIF8-MEM<sub>C</sub>, DC&#x0040;ZIF8, and CuS NPs all had a very wide absorption band in the near infrared region from 800 to 1,100&#xa0;nm. Therefore, a near-infrared laser of 808&#xa0;nm can be used as a heat source for photothermal effect. DC&#x0040;ZIF8-MEM<sub>C</sub> had characteristic absorbance peaks from DOX (480&#xa0;nm) and CAT (400&#xa0;nm), confirming the successful loading of these two materials (<xref ref-type="fig" rid="F2">Figure 2D</xref>).</p>
<p>By recording Fourier transform infrared (FTIR) spectra, the prepared DC&#x0040;ZIF8-MEM<sub>C</sub> was further characterized. As depicted in <xref ref-type="fig" rid="F2">Figure 2E</xref>, DC&#x0040;ZIF8-MEM<sub>C</sub> exhibited a characteristic peak of 1,700&#xa0;cm<sup>&#x2212;1</sup>, which was the C&#x3d;O stretching vibration of sodium citrate in CuS NP<sub>S</sub>, and a &#x2013;CH stretching vibration peak at 2,800&#xa0;cm<sup>&#x2212;1</sup>, which was consistent with the characteristic peak of DOX&#x00B7;HCl. DC&#x0040;ZIF8-MEM<sub>C</sub> had a characteristic peak of 3,500&#x2013;3,700&#xa0;cm<sup>&#x2212;1</sup>, which was abundant &#x2013;OH peaks on the surface of CAT and heterozygous membrane. The results of FTIR spectrum analysis and UV analysis were consistent, which showed that DC&#x0040;ZIF8-MEM<sub>C</sub> was successfully constructed.</p>
<p>Drug release <italic>in vitro</italic> showed pH-dependent manners (<xref ref-type="fig" rid="F2">Figure 2F</xref>). The cumulative release of DOX&#x00B7;HCl in pH 7.4, pH 6.5, and pH 5.0 media at 24&#xa0;h was 3.1% 11.9%, and 44.7%, respectively. There was little drug release in pH 7.4, indicating that the developed NPs were stable under physiological conditions. Compared with pH 5.0 group, release from pH 5.0&#xa0;&#x2b;&#xa0;NIR group was higher, indicating that NIR accelerated the drug release. Interestingly, pH sensitivity of DC&#x0040;ZIF8-MEM<sub>C</sub> was evident from <xref ref-type="fig" rid="F2">Figures 2G, H</xref>. When DC&#x0040;ZIF8-MEM<sub>C</sub> was in a neutral condition (pH 7.4 PBS), the morphology and size changed little for 8&#xa0;h (<xref ref-type="fig" rid="F2">Figure 2H</xref>). It degraded under acidic conditions (pH 5.0), and the size increased to 2,000&#xa0;nm, 10-fold bigger than that of PBS (pH 7.4) (<xref ref-type="fig" rid="F2">Figure 2G</xref>). Under acidic conditions, the release amount of the drug was significantly increased, which may be related to the degradation of the material at lower pH value (<xref ref-type="bibr" rid="B33">Wu et al., 2018</xref>). The imidazole groups from ZIF8 were protonated in an acidic environment, and the unstable coordination bonds between zinc ions and imidazole groups became unstable, leading to the disintegration of the skeleton and acceleration of the drug release.</p>
</sec>
<sec id="s4-2">
<title>Photothermal Properties</title>
<p>As shown in <xref ref-type="fig" rid="F3">Figures 3A, B</xref>, the temperature rise followed a concentration-dependent manner. The temperature of the water increased by only 2.1&#xb0;C. At concentrations of 60, 125, 250&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>, DC&#x0040;ZIF8-MEM<sub>C</sub> increased by 9.5&#xb0;C, 17.7&#xb0;C, and 28.4&#xb0;C, respectively (<xref ref-type="fig" rid="F3">Figures 3A, B</xref>). Furthermore, the temperature increased with power. The temperature increased by 17.4&#xb0;C when the concentration was 125&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>, and the power density of the 808&#xa0;nm laser was 2.0&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup> (<xref ref-type="fig" rid="F3">Figures 3C, D</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Photothermal images of DC&#x0040;ZIF8-MEM<sub>C</sub> with various concentrations by FLIR <bold>(A)</bold>. Temperature curves by changing concentration of DC&#x0040;ZIF8-MEM<sub>C</sub> with 808&#xa0;nm near infrared (NIR) at 2&#xa0;W&#xb7;cm<sup>&#x2212;2</sup> for 5&#xa0;min <bold>(B)</bold>. Photothermal images of DC&#x0040;ZIF8-MEM<sub>C</sub> with various laser power densities by FLIR <bold>(C)</bold>. Temperature curves of DC&#x0040;ZIF8-MEM<sub>C</sub> by changing the laser power density <bold>(D)</bold>. Temperature variations of DC&#x0040;ZIF8-MEM<sub>C</sub> by repeating on/off (2&#xa0;W&#xa0;cm<sup>&#x2212;2</sup>) <bold>(E)</bold>. Temperature fitting curve of DC&#x0040;ZIF8-MEM<sub>C</sub> <bold>(F)</bold>. The O<sub>2</sub>-generating behavior of DC&#x0040;ZIF8-MEM<sub>C</sub>, DC&#x0040;ZIF8-MEM, PBS, and free CAT solution in the presence of H<sub>2</sub>O<sub>2</sub>. Inset is the corresponding image of these four solutions <bold>(G)</bold>. Fluorescence absorption curves of ruthenium (II) dichloride [Ru (DPP)<sub>3</sub>Cl<sub>2</sub>] incubation with DC&#x0040;ZIF8-MEM<sub>C</sub> <bold>(H)</bold>. The H<sub>2</sub>O<sub>2</sub> consumption kinetics of free catalase (CAT), DC&#x0040;ZIF8-MEM<sub>C</sub>, and DC&#x0040;ZIF8-MEM at 37&#xb0;C <bold>(I)</bold>. The relative enzymatic activity of free CAT and DC&#x0040;ZIF8-MEM<sub>C</sub> after treating with protease K for different incubation times <bold>(J)</bold>.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g003.tif"/>
</fig>
<p>Moreover, by measuring the rising/falling temperature, it was found that the photothermal conversion was stable. The photothermal conversion efficiency was calculated to be 51.5%, consistent with a report (<xref ref-type="bibr" rid="B25">Shi et al., 2018</xref>), indicating the excellent photothermal performance of DC&#x0040;ZIF8-MEM<sub>C</sub> (<xref ref-type="fig" rid="F3">Figures 3E, F</xref>). Intriguingly, the photothermal conversion efficiency of DC&#x0040;ZIF8 was 54%, similar to that of DC&#x0040;ZIF8-MEM<sub>C</sub>, which indicated that there was no influence of membrane coating on photothermal property (<xref ref-type="sec" rid="s12">Supplementary Figure S6</xref>).</p>
</sec>
<sec id="s4-3">
<title>O<sub>2</sub> Generation <italic>in vitro</italic>
</title>
<p>The <italic>in situ</italic> O<sub>2</sub> production was measured by using a portable dissolved oxygen meter. As seen from <xref ref-type="fig" rid="F3">Figure 3G</xref>, the DC&#x0040;ZIF8-MEM and PBS groups did not generate any O<sub>2</sub>, while the DC&#x0040;ZIF8-MEM<sub>C</sub> and CAT groups generated time-dependent O<sub>2</sub> production due to the activity of CAT. Bubbles were visible in the EP tubes of free CAT and DC&#x0040;ZIF8-MEM<sub>C</sub>, while no bubbles were found with DC&#x0040;ZIF8-MEM and PBS (<xref ref-type="fig" rid="F3">Figure 3G</xref>). As an oxygen-sensitive dye, the fluorescence of Ru (DPP)<sub>3</sub>Cl<sub>2</sub> was quenched when O<sub>2</sub> was present in the solution. With the prolonging of reaction time, the fluorescence intensity of Ru (DPP)<sub>3</sub>Cl<sub>2</sub> decreased gradually (<xref ref-type="fig" rid="F3">Figure 3H</xref>). When the reaction time was 30&#xa0;min, the fluorescence intensity of Ru (DPP)<sub>3</sub>Cl<sub>2</sub> decreased to the lowest.</p>
</sec>
<sec id="s4-4">
<title>Catalytic Activity</title>
<p>CAT is an enzyme that catalyzes the decomposition of H<sub>2</sub>O<sub>2</sub> to generate O<sub>2</sub>. At 2&#xa0;h, 68% of H<sub>2</sub>O<sub>2</sub> was consumed with 2.5&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> of free CAT, 64% for DC&#x0040;ZIF8-MEM<sub>C</sub> with the same CAT concentration, indicating the same catalytic efficiency as that of free CAT (<xref ref-type="fig" rid="F3">Figure 3I</xref>, <xref ref-type="sec" rid="s12">Supplementary Figure S7</xref>). Comparatively, DC&#x0040;ZIF8-MEM consumed barely H<sub>2</sub>O<sub>2.</sub> Thus, the catalytic activity of DC&#x0040;ZIF8-MEM<sub>C</sub> indeed was derived from CAT. CAT is unstable under physiological conditions, due to enzymic digestion by protein K. At 12&#xa0;h, the catalytic activity decreased to 34% for free CAT, while 62% was maintained for DC&#x0040;ZIF8-MEM<sub>C</sub> (<xref ref-type="fig" rid="F3">Figure 3J</xref>). DC&#x0040;ZIF8-MEM<sub>C</sub> is capable of protecting CAT from degradation, which is useful for CAT delivery to maintain catalytic activity <italic>in vivo</italic>.</p>
</sec>
<sec id="s4-5">
<title>Cellular Uptake</title>
<p>To localize the cells, the cell nuclei were stained blue by Heochst-33258. The traffic of DOX&#x00B7;HCl inside the cells could be visualized by its intrinsic red fluorescence (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The fluorescence intensity of DC&#x0040;ZIF8-MEM<sub>C</sub> was stronger than that of other treatment groups, presenting the improved cellular uptake through endocytosis (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The relative fluorescence intensities were quantified, which suggested a higher uptake efficiency of DC&#x0040;ZIF8-MEM<sub>C</sub>, consistent with the result of qualitative analysis (<xref ref-type="fig" rid="F4">Figure 4B</xref>, <xref ref-type="sec" rid="s12">Supplementary Figure S8</xref>). It was attributed from MEM coating, which was helpful for accumulation at the tumor sites by passive targeting (<xref ref-type="bibr" rid="B9">Jiang et al., 2017</xref>; <xref ref-type="bibr" rid="B35">Ye et al., 2019</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Fluorescence images of mouse breast cancer cells (4T1) incubated with different samples for 4&#xa0;h, scale bar&#xa0;&#x3d;&#xa0;100&#xa0;&#xb5;m <bold>(A)</bold>. Cellular uptake efficiency of different samples to 4T1 cells by microplate reader <bold>(B)</bold>. Cytotoxicity of 4T1 cells incubated with different samples at various concentrations for 24&#xa0;h <bold>(C)</bold>. Labeling of live and dead cells by calcein AM/propidium iodide (PI) for different samples; scale bar&#xa0;&#x3d;&#xa0;200&#xa0;&#x3bc;m <bold>(D)</bold>. Cytotoxicity of 4T1 cells incubated with different samples at various concentrations in hypoxia incubator for 24&#xa0;h <bold>(E)</bold>. &#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.05, &#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g004.tif"/>
</fig>
</sec>
<sec id="s4-6">
<title>Antitumor Activity <italic>in vitro</italic>
</title>
<p>The <italic>in vitro</italic> tumor ablation was measured by MTT assays. The cell killing efficiency was dose dependent (<xref ref-type="fig" rid="F4">Figure 4C</xref>). When concentration was at 5&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>, the cell viability was 59%, 19% for free DOX&#x00B7;HCl, DC&#x0040;ZIF8-MEM<sub>C</sub>, respectively. Under laser irradiation, the cell viability of groups treated with DC&#x0040;ZIF8-MEM<sub>C</sub> decreased to 11%. DC&#x0040;ZIF8-MEM<sub>C</sub> indicated that a combination of CT and PTT as well as CAT was better than monotherapy alone.</p>
<p>As seen in <xref ref-type="fig" rid="F4">Figure 4E</xref>, both DC&#x0040;ZIF8-MEM<sub>C</sub> and DC&#x0040;ZIF8-MEM exhibited dose-dependent cytotoxicity. Under hypoxia condition (1% O<sub>2</sub>), compared with DC&#x0040;ZIF8-MEM, the cell viability of DC&#x0040;ZIF8-MEM<sub>C</sub> decreased significantly, demonstrating that the O<sub>2</sub> produced by CAT could alleviate hypoxia-induced resistance to DOX (12 versus 51% at 0.5&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>). These results could explain, to some extent, why the treatment effect of DC&#x0040;ZIF8-MEM<sub>C</sub> was much better than DC&#x0040;ZIF8-MEM <italic>in vivo</italic> experiment.</p>
<p>In addition, when the concentration of NPs was 120&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup>, the cell survival rate of C&#x0040;ZIF8-MEM was 80.0%, and the cell survival rate decreased to 35.0% after NIR (<xref ref-type="fig" rid="F7">Figure 7A</xref>). The results showed photo-responsive cytotoxicity of NPs.</p>
<p>To further evaluate the therapeutic outcome of the NPs, the treated cells were co-stained by calcein-AM and propidium iodide (PI) for live (green) and dead/late apoptotic cells (red), respectively (<xref ref-type="bibr" rid="B19">Liu et al., 2019</xref>). Both the control group and NIR group displayed strong green fluorescence (<xref ref-type="fig" rid="F4">Figure 4D</xref>). However, compared with DOX&#x00B7;HCl and DC&#x0040;ZIF8-MEM<sub>C</sub> groups, the red fluorescence was predominant for the DC&#x0040;ZIF8-MEM<sub>C</sub>&#xa0;&#x2b;&#xa0;NIR group, displaying a significant number of dead cells, which was in line with the results of cytotoxicity <italic>in vitro</italic> (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
</sec>
<sec id="s4-7">
<title>Intracellular Location</title>
<p>As shown in <xref ref-type="fig" rid="F5">Figure 5A</xref>, there were orange spots that emerged from the red and green channels, an evidence that red fluorescence of the majority of DC&#x0040;ZIF8-MEM<sub>C</sub> was in colocalization with green fluorescence (endosomes/lysosomes) at 0.5&#xa0;h. Over time, the amount of orange spots was weakened, and red color was evenly distributed throughout the cytoplasm, which showed minimal colocalization with the green fluorescence of the endo/lysosomes. The decreased colocalization signal of green and red fluorescence was visualized after 2&#xa0;h due to the ongoing intracellular transport and rapid endosomal escape. Meaningfully, most of the overlapped signals disappeared after 6&#xa0;h. The results presented that DC&#x0040;ZIF8-MEM<sub>C</sub> entered the lysosome and then escaped into the cytoplasm after uptake into the cell. To semiquantitatively evaluate the capacity of endosomal escape for DC&#x0040;ZIF8-MEM<sub>C</sub>, the index of colocalization and line scanning profiles of fluorescent intensity of the selected 4T1 cells were calculated by ImageJ software, as given in <xref ref-type="fig" rid="F5">Figures 5B, C</xref>.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Intracellular distribution fluorescence imaging of DC&#x0040;ZIF8-MEM<sub>C</sub> at different times by confocal laser microscopy (CLMS); scale bar&#xa0;&#x3d;&#xa0;50&#xa0;&#x3bc;m <bold>(A)</bold>. Line-scan profiles of DC&#x0040;ZIF8-MEM<sub>C</sub> and Lysotracker after 0.5, 2, and 6&#xa0;h incubation by ImageJ software. The level of the overlapped green line and red line is negatively correlated to endosomal escape of DC&#x0040;ZIF8-MEM<sub>C</sub> <bold>(B)</bold>. The index of colocalization of endocytosed DC&#x0040;ZIF8-MEM<sub>C</sub> (red) and endosome (green) was calculated by ImageJ software <bold>(C)</bold>. Cellular uptake of different samples incubated with RAW 264.7 cells for 24&#xa0;h by fluorescent microscope; scale bar&#xa0;&#x3d;&#xa0;100&#xa0;&#xb5;m <bold>(D)</bold>. Cellular uptake efficiency of different samples to RAW 264.7cells by microplate reader <bold>(E)</bold>. Fluorescence images of 4T1 cells incubated with different samples and then stained with Ru (DPP)<sub>3</sub>Cl<sub>2</sub>; scale bar&#xa0;&#x3d;&#xa0;50&#xa0;&#x3bc;m <bold>(F)</bold>. &#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.05, &#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g005.tif"/>
</fig>
<p>These results jointly corroborated the efficient endosomal/lysosomal escape behaviors of DC&#x0040;ZIF8-MEM<sub>C</sub>, which was attributed to the ZIF8 frame. Under the lysosome pH (pH 4.5&#x2013;5.5), the ZIF8 moiety could release the 2-methylimidazole ligand, which initiated the &#x201c;proton-sponge&#x201d; effect due to the protonation of imidazole rings and resulted in the rupture of lysosome membrane. (<xref ref-type="bibr" rid="B20">Liu Z et al., 2021</xref>). The rapid lysosomal escape capability of DC&#x0040;ZIF8-MEM<sub>C</sub> was beneficial to maintain the enzymatic activity of CAT and the therapeutic activity of DOX from lysosome to cytoplasm (<xref ref-type="bibr" rid="B30">Varkouhi et al., 2011</xref>).</p>
</sec>
<sec id="s4-8">
<title>Immune Evasion</title>
<p>Red fluorescence was strong for DOX&#x00B7;HCl group, while weak it was for DC&#x0040;ZIF8-MEM<sub>C</sub> group (<xref ref-type="fig" rid="F5">Figure 5D</xref>). As shown in <xref ref-type="fig" rid="F5">Figure 5E</xref>, the uptake rate of DC&#x0040;ZIF8-MEM<sub>C</sub> by RAW 264.7 cells were significantly lower than those of the other two groups, displaying that NPs camouflaged by blood cell membranes could avoid the phagocytosis of immune cells. As natural stealth coating, the cell membrane could alleviate immunogenicity and enhance biocompatibility (<xref ref-type="bibr" rid="B6">Graham and Unger, 2018</xref>).</p>
</sec>
<sec id="s4-9">
<title>
<bold>Intracellular Oxygen Determination</bold>
</title>
<p>Oxygen probe Ru(DPP)<sub>3</sub>Cl<sub>2</sub> was applied for intracellular determination. The fluorescence of Ru(DPP)<sub>3</sub>Cl<sub>2</sub> would be weakened in the presence of abundant O<sub>2</sub>. As from <xref ref-type="fig" rid="F5">Figure 5F</xref>, compared with the control group, the red fluorescence of C&#x0040;ZIF8-MEM was strong and predominant, while that of the C&#x0040;ZIF8-MEM<sub>C</sub> group was weak and marginal. For C&#x0040;ZIF8-MEM without embedded CAT, the fluorescence of Ru (DPP)<sub>3</sub>Cl<sub>2</sub> barely changed. However, the fluorescence change was weak due to the O<sub>2</sub> generation for the C&#x0040;ZIF8-MEM<sub>C</sub> group. Moreover, the fluorescence tended to be weaker with the increase in CAT concentration of C&#x0040;ZIF8-MEM<sub>C.</sub> The results verified that the intracellular O<sub>2</sub> generation of C&#x0040;ZIF8-MEM<sub>C</sub> originated from embedding the CAT.</p>
</sec>
<sec id="s4-10">
<title>Antitumor Effect <italic>in vivo</italic>
</title>
<p>The experimentation for the therapeutic model is shown in <xref ref-type="fig" rid="F6">Figure 6A</xref>. The antitumor effect was monitored by measuring the tumor size using a caliper every other day. With PBS or C&#x0040;ZIF8-MEM treatment, the tumor grew rapidly over time (<xref ref-type="fig" rid="F6">Figure 6D</xref>). Without irradiation, the DC&#x0040;ZIF8-MEM<sub>C</sub> showed moderate tumor inhibition due to the CT of DOX&#x00B7;HCl and hypoxic improvement of CAT. Combined with irradiation, the tumor inhibition effect was significantly elevated (<xref ref-type="fig" rid="F6">Figure 6D</xref>). The tumor weight was only 0.12&#xa0;g for the DC&#x0040;ZIF8-MEM<sub>C</sub>&#xa0;&#x2b;&#xa0;NIR group, while the tumor weights were 1.19, 1.13, 0.57, and 0.57&#xa0;g for DOX&#x00B7;HCl, DC&#x0040;ZIF8-MEM, DC&#x0040;ZIF8-MEM&#xa0;&#x2b;&#xa0;NIR, and DC&#x0040;ZIF8-MEM<sub>C</sub>, respectively (<xref ref-type="fig" rid="F6">Figure 6E</xref>). It could be clearly seen from the photographs of the extracted tumor tissues after treatment that the tumors treated with DC&#x0040;ZIF8-MEM<sub>C</sub> plus irradiation were ablated significantly (<xref ref-type="fig" rid="F6">Figure 6F</xref>). Interestingly, compared with the DC&#x0040;ZIF8-MEM&#xa0;&#x2b;&#xa0;NIR, the DC&#x0040;ZIF8-MEM<sub>C</sub>&#xa0;&#x2b;&#xa0;NIR group exhibited higher tumor inhibition effect, which may be attributed to amelioration of CAT for tumor hypoxia (<xref ref-type="fig" rid="F6">Figures 6D&#x2013;F</xref>). The results were consistent with cytotoxicity <italic>in vitro</italic>. Upon irradiation, DC&#x0040;ZIF8-MEM<sub>C</sub> displayed the most effectivity in tumor inhibition, superior to other groups, indicating the advantages of combined cancer therapy. Tumor slices had a large area of necrosis for the DC&#x0040;ZIF8-MEM<sub>C</sub>&#xa0;&#x2b;&#xa0;NIR group, consistent with the therapeutic effect (<xref ref-type="fig" rid="F6">Figure 6G</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Experimentation for the therapeutic model <bold>(A)</bold>. Photothermal images <italic>in vivo</italic> <bold>(B)</bold>. Temperature curves with 808&#xa0;nm NIR at 2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup> for 5&#xa0;min <bold>(C)</bold>. Relative tumor volumes of mice with different treatments <bold>(D)</bold>. Tumor weights of mice after different treatments <bold>(E)</bold>. Representative digital photographs of excised tumor tissues of mice with different treatments <bold>(F)</bold>. H&#x0026;E-stained images of tumor tissues from mice after different treatments on the 14th day; scale bar&#xa0;&#x3d;&#xa0;20&#xa0;&#xb5;m <bold>(G)</bold>. All the above data on mice in each group were averagely calculated (n&#xa0;&#x3d;&#xa0;5). &#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.05, &#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic>&#xa0;&#x3c;&#xa0;0.001.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g006.tif"/>
</fig>
</sec>
<sec id="s4-11">
<title>Photothermal Effect <italic>in vivo</italic>
</title>
<p>After continuous irradiation of the tumor site with the 808&#xa0;nm near-infrared laser (2&#xa0;W&#x00B7;cm<sup>&#x2212;2</sup>) for 5&#xa0;min, the near-infrared imaging image of the tumor site is shown in <xref ref-type="fig" rid="F6">Figure 6B</xref>. The infrared light intensity of the tumor site for the DC&#x0040;ZIF8-MEM<sub>C</sub> group was significantly stronger than that of the other groups. <xref ref-type="fig" rid="F6">Figure 6C</xref> shows the temperature rise curves of each group. The temperature of the DC&#x0040;ZIF8-MEM group and the DC&#x0040;ZIF8-MEM<sub>C</sub> group changed rapidly within 1&#xa0;min. After 5 min, the temperature of the tumor site increased to 40.1&#xb0;C, 46.6&#xb0;C, 52&#xb0;C, and 55.5&#xb0;C for PBS, DC&#x0040;ZIF8, DC&#x0040;ZIF8-MEM, and DC&#x0040;ZIF8-MEM<sub>C</sub>, respectively (<xref ref-type="fig" rid="F6">Figure 6C</xref>). It presented that DC&#x0040;ZIF8-MEM<sub>C</sub> played an effective photothermal effect.</p>
</sec>
<sec id="s4-12">
<title>Biocompatibility and Safety</title>
<p>The biocompatibility of the NPs was evaluated. The cell viability of C&#x0040;ZIF8-MEM displayed more than 80%, exhibiting good biocompatibility (<xref ref-type="fig" rid="F7">Figure 7A</xref>, <xref ref-type="sec" rid="s12">Supplementary Figure S9</xref>). The positive control (deionized water) showed obvious hemolysis, with HR as high as 100%. There was no hemolysis found for DC&#x0040;ZIF8-MEM<sub>C</sub> and PBS. HR of DC&#x0040;ZIF8-MEM<sub>C</sub> was less than 2% at a concentration as high as 300&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="F7">Figure 7B</xref>). Therefore, DC&#x0040;ZIF8-MEM<sub>C</sub> was highly biocompatible and could be directly administered by intravenous injection. There was no obvious decrease in body weight for all treatment groups except the DOX&#x00B7;HCl group (<xref ref-type="fig" rid="F7">Figure 7C</xref>). Additionally, no significant histopathology changes were noticed for the main organs such as the heart, liver, spleen, lungs, and kidneys, suggesting invisible short-term toxicity during treatments (<xref ref-type="fig" rid="F7">Figure 7D</xref>). These results demonstrated DC&#x0040;ZIF8-MEM<sub>C</sub> as promising for biomedicine application with high bio-safety.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Cell viability of C&#x0040;ZIF8-MEM to 4T1 cells with and without NIR <bold>(A)</bold>. The hemolytic image (left) and hemolysis ratio of samples (right), PBS (a), 50&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> DC&#x0040;ZIF8-MEM<sub>C</sub> (b), 100&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> DC&#x0040;ZIF8-MEM<sub>C</sub> (c), 200&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> DC&#x0040;ZIF8-MEM<sub>C</sub> (d), 300&#xa0;&#x3bc;g&#x00B7;mL<sup>&#x2212;1</sup> DC&#x0040;ZIF8-MEM<sub>C</sub> (e), deionized water (f) <bold>(B)</bold>. Body weights of mice with different treatments <bold>(C)</bold>. H&#x0026;E analysis of major organs from mice after treatments; scale bar&#xa0;&#x3d;&#xa0;20&#xa0;&#xb5;m <bold>(D)</bold>.</p>
</caption>
<graphic xlink:href="fphar-13-850534-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In summary, biomimic DC&#x0040;ZIF8-MEM<sub>C</sub> was established and investigated. High DOX&#x00b7;HCl loading and self-generation of O<sub>2</sub> which enhanced CT and PTT, were realized. Furthermore, the superior controlled drug release, photothermal efficiency, and excellent biocompatibility of DC&#x0040;ZIF8-MEM<sub>C</sub> were retained for remarkable antitumor effect of chemo-thermo synergistic therapy. Our study sheds light on the great chemo-photothermal synergistic antitumor effect under the sensitization of CAT.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s8">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Experimental Animal Ethics Committee of Xuzhou Medical University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>ZZ contributed to the design of the experiments, conceptualization, data analysis, and revised the draft. ZL performed the experiments and analyzed the data. YH performed the characterization and data interpretation. YP and GY participated in the cell experiments. SW and CH participated in the data collection and methodology. YZ contributed to the methodology, conceptualization, formal analysis, and revised the draft. YY designed the work and wrote the draft. All authors approved the final version of the manuscript to be submitted.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work was supported by the National Nature Science Foundation of China (No. 81773643).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed nor endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.850534/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2022.850534/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>An H<sub>2</sub>O<sub>2</sub>-Responsive Nanocarrier for Dual-Release of Platinum Anticancer Drugs and O<sub>2</sub>: Controlled Release and Enhanced Cytotoxicity against Cisplatin Resistant Cancer Cells</article-title>. <source>Chem. Commun.</source> <volume>50</volume>, <fpage>9714</fpage>&#x2013;<lpage>9717</lpage>. <pub-id pub-id-type="doi">10.1039/c4cc03385j</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-type Macrophages on Triple Negative Breast Cancers</article-title>. <source>Adv. Mater.</source> <volume>31</volume>, <fpage>e1904997</fpage>. <pub-id pub-id-type="doi">10.1002/adma.201904997</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Polydopamine Coated Manganese Oxide Nanoparticles with Ultrahigh Relaxivity as Nanotheranostic Agents for Magnetic Resonance Imaging Guided Synergetic Chemo-/photothermal Therapy</article-title>. <source>Chem. Sci.</source> <volume>7</volume>, <fpage>6695</fpage>&#x2013;<lpage>6700</lpage>. <pub-id pub-id-type="doi">10.1039/c6sc01320a</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Recent Advancement of Imidazolate Framework (ZIF-8) Based Nanoformulations for Synergistic Tumor Therapy</article-title>. <source>Nanoscale</source> <volume>11</volume>, <fpage>21030</fpage>&#x2013;<lpage>21045</lpage>. <pub-id pub-id-type="doi">10.1039/c9nr06558j</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf3;th</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>A Simple Method for Determination of Serum Catalase Activity and Revision of Reference Range</article-title>. <source>Clin. Chim. Acta</source> <volume>196</volume>, <fpage>143</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/0009-8981(91)90067-m</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Unger</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Overcoming Tumor Hypoxia as a Barrier to Radiotherapy, Chemotherapy and Immunotherapy in Cancer Treatment</article-title>. <source>Int. J. Nanomedicine</source> <volume>13</volume>, <fpage>6049</fpage>&#x2013;<lpage>6058</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S140462</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Manganese&#x2010;Dioxide&#x2010;Coating&#x2010;Instructed Plasmonic Modulation of Gold Nanorods for Activatable Duplex&#x2010;Imaging&#x2010;Guided NIR&#x2010;II Photothermal&#x2010;Chemodynamic Therapy</article-title>. <source>Adv. Mater.</source> <volume>33</volume>, <fpage>2008540</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202008540</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moorthy</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Manivasagan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K. D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Fucoidan-coated CuS Nanoparticles for Chemo-And Photothermal Therapy against Cancer</article-title>. <source>Oncotarget</source> <volume>9</volume>, <fpage>12649</fpage>&#x2013;<lpage>12661</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.23898</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Men</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Red Blood Cell Membrane-Camouflaged Melanin Nanoparticles for Enhanced Photothermal Therapy</article-title>. <source>Biomaterials</source> <volume>143</volume>, <fpage>29</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.07.027</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Green tea Extract-Assembled Nanoclusters for Combinational Photothermal and Chemotherapy</article-title>. <source>J. Mater. Chem. B</source> <volume>7</volume>, <fpage>5972</fpage>&#x2013;<lpage>5982</lpage>. <pub-id pub-id-type="doi">10.1039/c9tb01546a</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Role of Hypoxia in Cancer Therapy by Regulating the Tumor Microenvironment</article-title>. <source>Mol. Cancer</source> <volume>18</volume>, <fpage>157</fpage>. <pub-id pub-id-type="doi">10.1186/s12943-019-1089-9</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Labunov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lazarouk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A Supersensitive Silicon Nanowire Array Biosensor for Quantitating Tumor Marker ctDNA</article-title>. <source>Biosens. Bioelectron.</source> <volume>181</volume>, <fpage>113147</fpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2021.113147</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Macrophage-hitchhiking Supramolecular Aggregates of CuS Nanoparticles for Enhanced Tumor Deposition and Photothermal Therapy</article-title>. <source>Nanoscale Horiz</source> <volume>6</volume>, <fpage>907</fpage>&#x2013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1039/d1nh00291k</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q. L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Supramolecular Nanosystem Based on Pillararene-Capped CuS Nanoparticles for Targeted Chemo-Photothermal Therapy</article-title>. <source>ACS Appl. Mater. Inter.</source> <volume>10</volume>, <fpage>29314</fpage>&#x2013;<lpage>29324</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b09330</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>7</volume>, <fpage>293</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00293</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Enzyme-MOF (Metal-organic Framework) Composites</article-title>. <source>Chem. Soc. Rev.</source> <volume>46</volume>, <fpage>3386</fpage>&#x2013;<lpage>3401</lpage>. <pub-id pub-id-type="doi">10.1039/c7cs00058h</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Multifunctional Gold Nanoshells on Silica Nanorattles: a Platform for the Combination of Photothermal Therapy and Chemotherapy with Low Systemic Toxicity</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>50</volume>, <fpage>891</fpage>&#x2013;<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201002820</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Zeolite Imidazolate Frameworks-67 Precursor to Fabricate a Highly Active Cobalt-Embedded N-Doped Porous Graphitized Carbon Catalyst for the Thermal Decomposition of Ammonium Perchlorate</article-title>. <source>ACS Omega</source> <volume>6</volume>, <fpage>25440</fpage>&#x2013;<lpage>25446</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.1c03427</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Oxygen-Self-Supplying and HIF-1&#x3b1;-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy</article-title>. <source>ACS Appl. Mater. Inter.</source> <volume>11</volume>, <fpage>48261</fpage>&#x2013;<lpage>48270</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b18112</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A Nature&#x2010;Inspired Metal-Organic Framework Discriminator for Differential Diagnosis of Cancer Cell Subtypes</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>60</volume>, <fpage>15436</fpage>&#x2013;<lpage>15444</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202102286</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>C&#xf4;t&#xe9;</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Uribe-Romo</surname>
<given-names>F. J.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Exceptional Chemical and thermal Stability of Zeolitic Imidazolate Frameworks</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>103</volume>, <fpage>10186</fpage>&#x2013;<lpage>10191</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0602439103</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phua</surname>
<given-names>S. Z. F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>W. Q.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Thanabalu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor</article-title>. <source>Acs Nano</source> <volume>13</volume>, <fpage>4742</fpage>&#x2013;<lpage>4751</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.9b01087</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piao</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Y. Z.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Erythrocyte Membrane Is an Alternative Coating to Polyethylene Glycol for Prolonging the Circulation Lifetime of Gold Nanocages for Photothermal Therapy</article-title>. <source>Acs Nano</source> <volume>8</volume>, <fpage>10414</fpage>&#x2013;<lpage>10425</lpage>. <pub-id pub-id-type="doi">10.1021/nn503779d</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samanta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gilkes</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Semenza</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Hypoxia-inducible Factors Are Required for Chemotherapy Resistance of Breast Cancer Stem Cells</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>111</volume>, <fpage>E5429</fpage>&#x2013;<lpage>E5438</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1421438111</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Tumor-targeting CuS Nanoparticles for Multimodal Imaging and Guided Photothermal Therapy of Lymph Node Metastasis</article-title>. <source>Acta Biomater.</source> <volume>72</volume>, <fpage>256</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2018.03.035</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy</article-title>. <source>Adv. Mater.</source> <volume>28</volume>, <fpage>7143</fpage>&#x2013;<lpage>7148</lpage>. <pub-id pub-id-type="doi">10.1002/adma.201602111</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>K. Z.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Zeolitic Imidazolate Framework-8 as Efficient pH-Sensitive Drug Delivery Vehicle</article-title>. <source>Dalton Trans.</source> <volume>41</volume>, <fpage>6906</fpage>&#x2013;<lpage>6909</lpage>. <pub-id pub-id-type="doi">10.1039/c2dt30357d</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatrowski</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Nathan</surname>
<given-names>C. F.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Production of Large Amounts of Hydrogen Peroxide by Human Tumor Cells</article-title>. <source>Cancer Res.</source> <volume>51</volume>, <fpage>794</fpage>&#x2013;<lpage>798</lpage>. </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Sub-10-nm Pd Nanosheets with Renal Clearance for Efficient Near-Infrared Photothermal Cancer Therapy</article-title>. <source>Small</source> <volume>10</volume>, <fpage>3139</fpage>&#x2013;<lpage>3144</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201303631</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varkouhi</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Scholte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Storm</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haisma</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Endosomal Escape Pathways for Delivery of Biologicals</article-title>. <source>J. Control Release</source> <volume>151</volume>, <fpage>220</fpage>&#x2013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2010.11.004</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaupel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Tumor Hypoxia: Causative Mechanisms, Microregional Heterogeneities, and the Role of Tissue-Based Hypoxia Markers</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>923</volume>, <fpage>77</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-38810-6_11</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Win</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs</article-title>. <source>Biomaterials</source> <volume>26</volume>, <fpage>2713</fpage>&#x2013;<lpage>2722</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2004.07.050</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Biocompatible and Biodegradable Zeolitic Imidazolate Framework/polydopamine Nanocarriers for Dual Stimulus Triggered Tumor Thermo-Chemotherapy</article-title>. <source>Biomaterials</source> <volume>162</volume>, <fpage>132</fpage>&#x2013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.02.022</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A Smart pH-Sensitive Delivery System for Enhanced Anticancer Efficacy via Paclitaxel Endosomal Escape</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>10</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00010</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy</article-title>. <source>ACS Appl. Mater. Inter.</source> <volume>11</volume>, <fpage>15262</fpage>&#x2013;<lpage>15275</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b00897</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phospholipid Membrane-Decorated Deep-Penetrated Nanocatalase Relieve Tumor Hypoxia to Enhance Chemo-Photodynamic Therapy</article-title>. <source>Acta Pharm. Sin. B</source> <volume>10</volume>, <fpage>2246</fpage>&#x2013;<lpage>2257</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2020.06.004</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>IR-780 Dye Loaded Tumor Targeting Theranostic Nanoparticles for NIR Imaging and Photothermal Therapy</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>6853</fpage>&#x2013;<lpage>6861</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.05.071</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Transforming Weakness into Strength: Photothermal-Therapy-Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy as a Combination Anticancer Treatment</article-title>. <source>Adv. Mater.</source> <volume>31</volume>, <fpage>e1805936</fpage>. <pub-id pub-id-type="doi">10.1002/adma.201805936</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Catalase-loaded Cisplatin-Prodrug-Constructed Liposomes to Overcome Tumor Hypoxia for Enhanced Chemo-Radiotherapy of Cancer</article-title>. <source>Biomaterials</source> <volume>138</volume>, <fpage>13</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.05.025</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang X</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Machuki</surname>
<given-names>J. O.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Gold Cube-In-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging</article-title>. <source>ACS Nano</source> <volume>13</volume>, <fpage>5306</fpage>&#x2013;<lpage>5325</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.8b09786</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Improving Drug Accumulation and Photothermal Efficacy in Tumor Depending on Size of ICG Loaded Lipid-Polymer Nanoparticles</article-title>. <source>Biomaterials</source> <volume>35</volume>, <fpage>6037</fpage>&#x2013;<lpage>6046</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.04.019</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Temperature-Sensitive Lipid-Coated Carbon Nanotubes for Synergistic Photothermal Therapy and Gene Therapy</article-title>. <source>ACS Nano</source> <volume>15</volume>, <fpage>6517</fpage>&#x2013;<lpage>6529</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c08790</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Temperature-Correlated Afterglow of a Semiconducting Polymer Nanococktail for Imaging-Guided Photothermal Therapy</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>57</volume>, <fpage>3938</fpage>&#x2013;<lpage>3942</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201712550</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Dual Factor Activated Metal-Organic Framework Hybrid Nanoplatform for Photoacoustic Imaging and Synergetic Photo-Chemotherapy</article-title>. <source>Nanoscale</source> <volume>11</volume>, <fpage>20630</fpage>&#x2013;<lpage>20637</lpage>. <pub-id pub-id-type="doi">10.1039/c9nr06349h</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Negative Surface Shielded Polymeric Micelles with Colloidal Stability for Intracellular Endosomal/Lysosomal Escape</article-title>. <source>Mol. Pharm.</source> <volume>15</volume>, <fpage>5374</fpage>&#x2013;<lpage>5386</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00842</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Weerapana</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tsung</surname>
<given-names>C. K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Optimized Metal-Organic-Framework Nanospheres for Drug Delivery: Evaluation of Small-Molecule Encapsulation</article-title>. <source>ACS Nano</source> <volume>8</volume>, <fpage>2812</fpage>&#x2013;<lpage>2819</lpage>. <pub-id pub-id-type="doi">10.1021/nn406590q</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C. X.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1/pd-L1 Axis</article-title>. <source>Small</source> <volume>14</volume>, <fpage>e1801120</fpage>. <pub-id pub-id-type="doi">10.1002/smll.201801120</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>